This article talks about how much money it takes to make cannabis products compared to other things like cigarettes, alcohol, or medicine. It shows that making cannabis products needs more money than the others. Because of this, it is hard for cannabis companies to grow by themselves without getting help from outside sources. The article also looks at how different big cannabis companies use money in different ways and what effects it has on their profits. Read from source...

1. The author claims that cannabis is more capital-intensive than tobacco, alcohol, pharmaceuticals, or general consumer products, but does not provide any evidence or comparison to support this claim. It seems like a subjective opinion rather than a factual statement.
2. The author mentions that the industry has managed to reduce capital intensity slightly since then, and the group now measures 1.54x capital/sales, but does not explain how or why this reduction occurred, or what factors influenced it. It is unclear if this reduction is sustainable or significant in the long term.
3. The author argues that high capital intensity has severe implications for internally fundable growth, and that growth requires external financing. However, he does not consider other possible alternatives or strategies to overcome the challenges of high capital intensity, such as cost reduction, efficiency improvement, innovation, or partnership. He seems to present a pessimistic view of the industry's potential for growth without acknowledging its strengths and opportunities.
4. The author uses S3 to help but not eliminate the issue of capital intensity, but does not explain what S3 is, how it works, or what benefits it offers to the cannabis companies. It seems like a vague reference that lacks clarity and substance.